ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Quinine Market Outlook, In‑Depth Analysis & Forecast to 2031
Published Date: November 2025
|
Report Code: QYRE-Auto-4S17124
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global Quinine Market Research Report 2024
BUY CHAPTERS

Global Quinine Market Outlook, In‑Depth Analysis & Forecast to 2031

Code: QYRE-Auto-4S17124
Report
November 2025
Pages:150
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Pfizer Pharmaceuticals
Sanofi
Bayer
TEVA
Viatris
Ipca Laboratories
Huateng Pharma
URL Pharma

Quinine Market

The global Quinine market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Quinine is a natural alkaloid compound derived from the bark of the cinchona tree, native to the Andean region of South America. It has been historically used for its antimalarial properties, but it also possesses other pharmacological effects.
From a downstream perspective, Beverages accounted for % of 2024 revenue, surging to US$ million by 2031 (CAGR: % from 2025–2031).
Quinine leading manufacturers including URL Pharma, Pfizer Pharmaceuticals, Sanofi, Bayer, Teva, Viatris, Ipca Laboratories, Huateng Pharma, etc., dominate supply; the top five capture approximately % of global revenue, with URL Pharma leading 2024 sales at US$ million.
Regional Outlook:
North America rose from US$ million in 2024 to a forecast US$ million by 2031 (CAGR %).
Asia‑Pacific will expand from US$ million to US$ million (CAGR  %), led by China (US$ million in 2024, % share rising to % by 2031), Japan (CAGR %), South Korea (CAGR %), and Southeast Asia (CAGR %).
Europe is set to grow from US$ million to US$ million (CAGR %), with Germany projected to hit US$ million by 2031 (CAGR %).

Report Includes:

This definitive report equips CEOs, marketing directors, and investors with a 360° view of the global Quinine market, seamlessly integrating production capacity and sales performance across the value chain. It analyzes historical production, revenue, and sales data (2020–2024) and delivers forecasts through 2031, illuminating demand trends and growth drivers.
By segmenting the market by Type and by Application, the study quantifies volume and value, growth rates, technical innovations, niche opportunities, and substitution risks, and analyzes downstream customers distribution pattern.
Granular regional insights cover five major markets—North America, Europe, APAC, South America, and MEA—with in‑depth analysis of 20+ countries. Each region’s dominant products, competitive landscape, and downstream demand trends are clearly detailed.
Critical competitive intelligence profiles manufacturers—capacity, sales volume, revenue, margins, pricing strategies, and major customers—and dissects the top-player positioning across product lines, applications, and regions to reveal strategic strengths.
A concise supply‑chain overview maps upstream suppliers, manufacturing technologies, cost structures, and distribution dynamics to identify strategic gaps and unmet demand.
Market Segmentation

Scope of Quinine Market Report

Report Metric Details
Report Name Quinine Market
Segment by Type
  • Food Grade
  • Pharma Grade
Segment by Application
  • Beverages
  • Pharmaceuticals
  • Others
Production by Region
  • North America
  • Europe
  • China
  • Japan
Sales by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company URL Pharma, Pfizer Pharmaceuticals, Sanofi, Bayer, Teva, Viatris, Ipca Laboratories, Huateng Pharma
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Defines the Quinine study scope, segments the market by Type and by Application, etc, highlights segment size and growth potential.
  • Chapter 2: Offers current market state, projects global revenue and sales to 2031, pinpointing high consumption regions and emerging market catalysts
  • Chapter 3: Maps global production capacity, utilization, and market share (2020–2031), identifies efficient hubs, reveals regulatory/trade policy impacts and bottlenecks.
  • Chapter 4: Dissects the manufacturer landscape—ranks by volume and revenue, analyzes profitability and pricing, maps production bases, details manufacturer performance by product type and evaluates concentration alongside M&A moves.
  • Chapter 5: Unlocks high margin product segments—compares sales, revenue, ASP, and technology differentiators, highlighting growth niches and substitution risks
  • Chapter 6: Targets downstream market opportunities—evaluates sales, revenue, and pricing by Application, identifies emerging use cases, and profiles leading customers by region and by Application.
  • Chapter 7: North America—breaks down sales and revenue by Type, by Application and country, profiles key manufacturers and assesses growth drivers and barriers.
  • Chapter 8: Europe—analyses regional sales, revenue and market by Type, by Application and manufacturers, flagging drivers and barriers.
  • Chapter 9: Asia Pacific—quantifies sales and revenue by Type, by Application, and region/country, profiles top manufacturers, and uncovers high potential expansion areas.
  • Chapter 10: Central & South America—measures sales and revenue by Type, by Application, and country, profiles top manufacturers, and identifies investment opportunities and challenges.
  • Chapter 11: Middle East and Africa—evaluates sales and revenue by Type, by Application, and country, profiles key manufacturers, and outlines investment prospects and market hurdles
  • Chapter 12: Profiles manufacturers in depth—details product specs, capacity, sales, revenue, margins; Top manufactures 2024 sales breakdowns by Product type, by Application, by sales region SWOT analysis, and recent strategic developments.
  • Chapter 13: Supply chain—analyses upstream raw materials and suppliers, manufacturing footprint and technology, cost drivers, plus downstream channels and distributor roles.
  • Chapter 14: Market dynamics—explores drivers, restraints, regulatory impacts, and risk mitigation strategies.
  • Chapter 15: Actionable conclusions and strategic recommendations.
  • Why This Report:
  • Beyond standard market data, this analysis provides a clear profitability roadmap—empowering you to:
  • Allocate capital strategically to high growth regions (Chapters 7–11) and margin rich segments (Chapter 5).
  • Negotiate from strength with suppliers (Chapter 13) and customers (Chapter 6) using cost and demand intelligence.
  • Outmaneuver competitors with granular insights into their operations, margins, and strategies (Chapters 4 and 12).
  • Secure your supply chain against disruptions through upstream and downstream visibility (Chapters 13 and 14).
  • Leverage this 360° intelligence to turn market complexity into actionable competitive advantage.

FAQ for this report

Who are the main players in the Quinine Market report?

Ans: The main players in the Quinine Market are URL Pharma, Pfizer Pharmaceuticals, Sanofi, Bayer, Teva, Viatris, Ipca Laboratories, Huateng Pharma

What are the Application segmentation covered in the Quinine Market report?

Ans: The Applications covered in the Quinine Market report are Beverages, Pharmaceuticals, Others

What are the Type segmentation covered in the Quinine Market report?

Ans: The Types covered in the Quinine Market report are Food Grade, Pharma Grade

1 Study Coverage
1.1 Introduction to Quinine: Definition, Properties, and Key Attributes
1.2 Market Segmentation by Type
1.2.1 Global Quinine Market Size by Type, 2020 VS 2024 VS 2031
1.2.2 Food Grade
1.2.3 Pharma Grade
1.3 Market Segmentation by Application
1.3.1 Global Quinine Market Size by Application, 2020 VS 2024 VS 2031
1.3.2 Beverages
1.3.3 Pharmaceuticals
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Quinine Revenue Estimates and Forecasts 2020-2031
2.2 Global Quinine Revenue by Region
2.2.1 Revenue Comparison: 2020 VS 2024 VS 2031
2.2.2 Historical and Forecasted Revenue by Region (2020--2031)
2.2.3 Global Revenue Market Share by Region (2020-2031)
2.3 Global Quinine Sales Estimates and Forecasts 2020-2031
2.4 Global Quinine Sales by Region
2.4.1 Sales Comparison: 2020 VS 2024 VS 2031
2.4.2 Historical and Forecasted Sales by Region (2020-2031)
2.4.3 Emerging Market Focus: Growth Drivers & Investment Trends
2.4.4 Global Sales Market Share by Region (2020-2031)
3 Global Production Analysis
3.1 Global Quinine Production Capacity and Utilization Rates (2020–2031)
3.2 Regional Production: Comparative Analysis (2020 VS 2024 VS 2031)
3.3 Regional Production Dynamics
3.3.1 Historic Production by Region (2020-2025)
3.3.2 Forecasted Production by Region (2026-2031)
3.3.3 Production Market Share by Region (2020-2031)
3.3.4 Regulatory and Trade Policy Impact on Production
3.3.5 Production Capacity Enablers and Constraints
3.4 Key Regional Production Hubs
3.4.1 North America
3.4.2 Europe
3.4.3 China
3.4.4 Japan
4 Competition by Manufacturers
4.1 Global Quinine Sales by Manufacturers
4.1.1 Global Sales Volume by Manufacturers (2020-2025)
4.1.2 Global Top 5 and Top 10 Manufacturers’Market Share by Sales Volume (2024)
4.2 Global Quinine Manufacturer Revenue Rankings and Tiers
4.2.1 Global Revenue (Value) by Manufacturers (2020-2025)
4.2.2 Global Key Manufacturer Revenue Ranking (2023 vs. 2024)
4.2.3 Revenue-Based Tier Segmentation (Tier 1, Tier 2, and Tier 3)
4.3 Manufacturer Profitability Profiles and Pricing Strategies
4.3.1 Gross Margin by Top Manufacturer (2020 VS 2024)
4.3.2 Manufacturer-Level Price Trends (2020-2025)
4.4 Key Manufacturers Manufacturing Base and Headquarters
4.5 Main Product Type Market Size by Manufacturers
4.5.1 Food Grade Market Size by Manufacturers
4.5.2 Pharma Grade Market Size by Manufacturers
4.6 Global Quinine Market Concentration and Dynamics
4.6.1 Global Market Concentration (CR5 and HHI)
4.6.2 Entrant/Exit Impact Analysis
4.6.3 Strategic Moves: M&A, Capacity Expansion, R&D Investment
5 Global Product Segmentation Analysis
5.1 Global Quinine Sales Performance by Type
5.1.1 Global Historical and Forecasted Sales by Type (2020-2031)
5.1.2 Global Sales Market Share by Type (2020-2031)
5.2 Global Quinine Revenue Trends by Type
5.2.1 Global Historical and Forecasted Revenue by Type (2020-2031)
5.2.2 Global Revenue Market Share by Type (2020-2031)
5.3 Global Average Selling Price (ASP) Trends by Type (2020-2031)
5.4 Product Technology Differentiation
5.5 Subtype Dynamics: Growth Leaders, Profitability and Risk
5.5.1 High-Growth Niches and Adoption Drivers
5.5.2 Profitability Hotspots and Cost Drivers
5.5.3 Substitution Threats
6 Global Downstream Application Analysis
6.1 Global Quinine Sales by Application
6.1.1 Global Historical and Forecasted Sales by Application (2020-2031)
6.1.2 Global Sales Market Share by Application (2020-2031)
6.1.3 High-Growth Application Identification
6.1.4 Emerging Application Case Studies
6.2 Global Quinine Revenue by Application
6.2.1 Global Historical and Forecasted Revenue by Application (2020-2031)
6.2.2 Revenue Market Share by Application (2020-2031)
6.3 Global Pricing Dynamics by Application (2020-2031)
6.4 Downstream Customer Analysis
6.4.1 Top Customers by Region
6.4.2 Top Customers by Application
7 North America
7.1 North America Sales Volume and Revenue (2020-2031)
7.2 North America Key Manufacturers Sales Revenue in 2024
7.3 North America Quinine Sales and Revenue by Type (2020-2031)
7.4 North America Quinine Sales and Revenue by Application (2020-2031)
7.5 North America Growth Accelerators and Market Barriers
7.6 North America Quinine Market Size by Country
7.6.1 North America Revenue by Country
7.6.2 North America Sales Trends by Country
7.6.3 US
7.6.4 Canada
7.6.5 Mexico
8 Europe
8.1 Europe Sales Volume and Revenue (2020-2031)
8.2 Europe Key Manufacturers Sales Revenue in 2024
8.3 Europe Quinine Sales and Revenue by Type (2020-2031)
8.4 Europe Quinine Sales and Revenue by Application (2020-2031)
8.5 Europe Growth Accelerators and Market Barriers
8.6 Europe Quinine Market Size by Country
8.6.1 Europe Revenue by Country
8.6.2 Europe Sales Trends by Country
8.6.3 Germany
8.6.4 France
8.6.5 U.K.
8.6.6 Italy
8.6.7 Russia
9 Asia-Pacific
9.1 Asia-Pacific Sales Volume and Revenue (2020-2031)
9.2 Asia-Pacific Key Manufacturers Sales Revenue in 2024
9.3 Asia-Pacific Quinine Sales and Revenue by Type (2020-2031)
9.4 Asia-Pacific Quinine Sales and Revenue by Application (2020-2031)
9.5 Asia-Pacific Quinine Market Size by Region
9.5.1 Asia-Pacific Revenue by Region
9.5.2 Asia-Pacific Sales Trends by Region
9.6 Asia-Pacific Growth Accelerators and Market Barriers
9.7 Southeast Asia
9.7.1 Southeast Asia Revenue by Country (2020 VS 2024 VS 2031)
9.7.2 Key Country Analysis: Indonesia, Vietnam, Thailand
9.8 China
9.9 Japan
9.10 South Korea
9.11 China Taiwan
9.12 India
10 Central and South America
10.1 Central and South America Sales Volume and Revenue (2020-2031)
10.2 Central and South America Key Manufacturers Sales Revenue in 2024
10.3 Central and South America Quinine Sales and Revenue by Type (2020-2031)
10.4 Central and South America Quinine Sales and Revenue by Application (2020-2031)
10.5 Central and South America Investment Opportunities and Key Challenges
10.6 Central and South America Quinine Market Size by Country
10.6.1 Central and South America Revenue Trends by Country (2020 VS 2024 VS 2031)
10.6.2 Brazil
10.6.3 Argentina
11 Middle East and Africa
11.1 Middle East and Africa Sales Volume and Revenue (2020-2031)
11.2 Middle East and Africa Key Manufacturers Sales Revenue in 2024
11.3 Middle East and Africa Quinine Sales and Revenue by Type (2020-2031)
11.4 Middle East and Africa Quinine Sales and Revenue by Application (2020-2031)
11.5 Middle East and Africa Investment Opportunities and Key Challenges
11.6 Middle East and Africa Quinine Market Size by Country
11.6.1 Middle East and Africa Revenue Trends by Country (2020 VS 2024 VS 2031)
11.6.2 GCC Countries
11.6.3 Turkey
11.6.4 Egypt
11.6.5 South Africa
12 Corporate Profile
12.1 URL Pharma
12.1.1 URL Pharma Corporation Information
12.1.2 URL Pharma Business Overview
12.1.3 URL Pharma Quinine Product Models, Descriptions and Specifications
12.1.4 URL Pharma Quinine Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.1.5 URL Pharma Quinine Sales by Product in 2024
12.1.6 URL Pharma Quinine Sales by Application in 2024
12.1.7 URL Pharma Quinine Sales by Geographic Area in 2024
12.1.8 URL Pharma Quinine SWOT Analysis
12.1.9 URL Pharma Recent Developments
12.2 Pfizer Pharmaceuticals
12.2.1 Pfizer Pharmaceuticals Corporation Information
12.2.2 Pfizer Pharmaceuticals Business Overview
12.2.3 Pfizer Pharmaceuticals Quinine Product Models, Descriptions and Specifications
12.2.4 Pfizer Pharmaceuticals Quinine Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.2.5 Pfizer Pharmaceuticals Quinine Sales by Product in 2024
12.2.6 Pfizer Pharmaceuticals Quinine Sales by Application in 2024
12.2.7 Pfizer Pharmaceuticals Quinine Sales by Geographic Area in 2024
12.2.8 Pfizer Pharmaceuticals Quinine SWOT Analysis
12.2.9 Pfizer Pharmaceuticals Recent Developments
12.3 Sanofi
12.3.1 Sanofi Corporation Information
12.3.2 Sanofi Business Overview
12.3.3 Sanofi Quinine Product Models, Descriptions and Specifications
12.3.4 Sanofi Quinine Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.3.5 Sanofi Quinine Sales by Product in 2024
12.3.6 Sanofi Quinine Sales by Application in 2024
12.3.7 Sanofi Quinine Sales by Geographic Area in 2024
12.3.8 Sanofi Quinine SWOT Analysis
12.3.9 Sanofi Recent Developments
12.4 Bayer
12.4.1 Bayer Corporation Information
12.4.2 Bayer Business Overview
12.4.3 Bayer Quinine Product Models, Descriptions and Specifications
12.4.4 Bayer Quinine Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.4.5 Bayer Quinine Sales by Product in 2024
12.4.6 Bayer Quinine Sales by Application in 2024
12.4.7 Bayer Quinine Sales by Geographic Area in 2024
12.4.8 Bayer Quinine SWOT Analysis
12.4.9 Bayer Recent Developments
12.5 Teva
12.5.1 Teva Corporation Information
12.5.2 Teva Business Overview
12.5.3 Teva Quinine Product Models, Descriptions and Specifications
12.5.4 Teva Quinine Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.5.5 Teva Quinine Sales by Product in 2024
12.5.6 Teva Quinine Sales by Application in 2024
12.5.7 Teva Quinine Sales by Geographic Area in 2024
12.5.8 Teva Quinine SWOT Analysis
12.5.9 Teva Recent Developments
12.6 Viatris
12.6.1 Viatris Corporation Information
12.6.2 Viatris Business Overview
12.6.3 Viatris Quinine Product Models, Descriptions and Specifications
12.6.4 Viatris Quinine Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.6.5 Viatris Recent Developments
12.7 Ipca Laboratories
12.7.1 Ipca Laboratories Corporation Information
12.7.2 Ipca Laboratories Business Overview
12.7.3 Ipca Laboratories Quinine Product Models, Descriptions and Specifications
12.7.4 Ipca Laboratories Quinine Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.7.5 Ipca Laboratories Recent Developments
12.8 Huateng Pharma
12.8.1 Huateng Pharma Corporation Information
12.8.2 Huateng Pharma Business Overview
12.8.3 Huateng Pharma Quinine Product Models, Descriptions and Specifications
12.8.4 Huateng Pharma Quinine Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.8.5 Huateng Pharma Recent Developments
13 Value Chain and Supply-Chain Analysis
13.1 Quinine Industry Chain
13.2 Quinine Upstream Materials Analysis
13.2.1 Raw Materials
13.2.2 Key Suppliers Market Share & Risk Assessment
13.3 Quinine Integrated Production Analysis
13.3.1 Manufacturing Footprint Analysis
13.3.2 Production Technology Overview
13.3.3 Regional Cost Drivers
13.4 Quinine Sales Channels and Distribution Networks
13.4.1 Sales Channels
13.4.2 Distributors
14 Quinine Market Dynamics
14.1 Industry Trends and Evolution
14.2 Market Growth Drivers and Emerging Opportunities
14.3 Market Challenges, Risks, and Restraints
15 Key Findings in the Global Quinine Study
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.1.1 Research Programs/Design
16.1.1.2 Market Size Estimation
16.1.1.3 Market Breakdown and Data Triangulation
16.1.2 Data Source
16.1.2.1 Secondary Sources
16.1.2.2 Primary Sources
16.2 Author Details
FEATURED COMPANIES
Pfizer Pharmaceuticals
Sanofi
Bayer
TEVA
Viatris
Ipca Laboratories
Huateng Pharma
URL Pharma
List of Tables
 Table 1. Global Quinine Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
 Table 2. Global Quinine Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
 Table 3. Global Quinine Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 4. Global Quinine Revenue by Region (2020-2025) & (US$ Million)
 Table 5. Global Quinine Revenue by Region (2026-2031) & (US$ Million)
 Table 6. Global Quinine Sales Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (Tons)
 Table 7. Global Quinine Sales by Region (2020-2025) & (Tons)
 Table 8. Global Quinine Sales by Region (2026-2031) & (Tons)
 Table 9. Emerging Market Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 10. Global Quinine Production Growth Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (Tons)
 Table 11. Global Quinine Production by Region (2020-2025) & (Tons)
 Table 12. Global Quinine Production by Region (2026-2031) & (Tons)
 Table 13. Global Quinine Sales by Manufacturers (2020-2025) & (Tons)
 Table 14. Global Quinine Sales Share by Manufacturers (2020-2025)
 Table 15. Global Quinine Revenue by Manufacturers (2020-2025) & (US$ Million)
 Table 16. Global Quinine Revenue Market Share by Manufacturers (2020-2025)
 Table 17. Global Key Manufacturers’Ranking Shift (2023 vs. 2024) (Based on Revenue)
 Table 18. Global Quinine by Manufacturer Tier (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Quinine as of 2024)
 Table 19. Global Quinine Average Gross Margin (%) by Manufacturer (2020 VS 2024)
 Table 20. Global Quinine Average Selling Price (ASP) by Manufacturers (2020-2025) & (US$/kg)
 Table 21. Key Manufacturers Quinine Manufacturing Base and Headquarters
 Table 22. Global Quinine Market Concentration Ratio (CR5 and HHI)
 Table 23. Key Market Entrant/Exit (2020-2024) – Drivers & Impact Analysis
 Table 24. Key Mergers & Acquisitions, Expansion Plans, R&D Investment
 Table 25. Global Quinine Sales by Type (2020-2025) & (Tons)
 Table 26. Global Quinine Sales by Type (2026-2031) & (Tons)
 Table 27. Global Quinine Revenue by Type (2020-2025) & (US$ Million)
 Table 28. Global Quinine Revenue by Type (2026-2031) & (US$ Million)
 Table 29. Global Quinine ASP by Type (2020-2031) & (US$/kg)
 Table 30. Technical Specifications by Key Product Type
 Table 31. Global Quinine Sales by Application (2020-2025) & (Tons)
 Table 32. Global Quinine Sales by Application (2026-2031) & (Tons)
 Table 33. Quinine High-Growth Sectors Demand CAGR (2024-2031)
 Table 34. Global Quinine Revenue by Application (2020-2025) & (US$ Million)
 Table 35. Global Quinine Revenue by Application (2026-2031) & (US$ Million)
 Table 36. Global Quinine ASP by Application (2020-2031) & (US$/kg)
 Table 37. Top Customers by Region
 Table 38. Top Customers by Application
 Table 39. North America Quinine Growth Accelerators and Market Barriers
 Table 40. North America Quinine Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 41. North America Quinine Sales (Tons) by Country (2020 VS 2024 VS 2031)
 Table 42. Europe Quinine Growth Accelerators and Market Barriers
 Table 43. Europe Quinine Revenue Grow Rate (CAGR) by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 44. Europe Quinine Sales (Tons) by Country (2020 VS 2024 VS 2031)
 Table 45. Asia-Pacific Quinine Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Asia-Pacific Quinine Sales (Tons) by Country (2020 VS 2024 VS 2031)
 Table 47. Asia-Pacific Quinine Growth Accelerators and Market Barriers
 Table 48. Southeast Asia Quinine Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 49. Central and South America Quinine Investment Opportunities and Key Challenges
 Table 50. Central and South America Quinine Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 51. Middle East and Africa Quinine Investment Opportunities and Key Challenges
 Table 52. Middle East and Africa Quinine Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 53. URL Pharma Corporation Information
 Table 54. URL Pharma Description and Major Businesses
 Table 55. URL Pharma Product Models, Descriptions and Specifications
 Table 56. URL Pharma Capacity, Sales (Tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2020-2025)
 Table 57. URL Pharma Sales Value Proportion by Product in 2024
 Table 58. URL Pharma Sales Value Proportion by Application in 2024
 Table 59. URL Pharma Sales Value Proportion by Geographic Area in 2024
 Table 60. URL Pharma Quinine SWOT Analysis
 Table 61. URL Pharma Recent Developments
 Table 62. Pfizer Pharmaceuticals Corporation Information
 Table 63. Pfizer Pharmaceuticals Description and Major Businesses
 Table 64. Pfizer Pharmaceuticals Product Models, Descriptions and Specifications
 Table 65. Pfizer Pharmaceuticals Capacity, Sales (Tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2020-2025)
 Table 66. Pfizer Pharmaceuticals Sales Value Proportion by Product in 2024
 Table 67. Pfizer Pharmaceuticals Sales Value Proportion by Application in 2024
 Table 68. Pfizer Pharmaceuticals Sales Value Proportion by Geographic Area in 2024
 Table 69. Pfizer Pharmaceuticals Quinine SWOT Analysis
 Table 70. Pfizer Pharmaceuticals Recent Developments
 Table 71. Sanofi Corporation Information
 Table 72. Sanofi Description and Major Businesses
 Table 73. Sanofi Product Models, Descriptions and Specifications
 Table 74. Sanofi Capacity, Sales (Tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2020-2025)
 Table 75. Sanofi Sales Value Proportion by Product in 2024
 Table 76. Sanofi Sales Value Proportion by Application in 2024
 Table 77. Sanofi Sales Value Proportion by Geographic Area in 2024
 Table 78. Sanofi Quinine SWOT Analysis
 Table 79. Sanofi Recent Developments
 Table 80. Bayer Corporation Information
 Table 81. Bayer Description and Major Businesses
 Table 82. Bayer Product Models, Descriptions and Specifications
 Table 83. Bayer Capacity, Sales (Tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2020-2025)
 Table 84. Bayer Sales Value Proportion by Product in 2024
 Table 85. Bayer Sales Value Proportion by Application in 2024
 Table 86. Bayer Sales Value Proportion by Geographic Area in 2024
 Table 87. Bayer Quinine SWOT Analysis
 Table 88. Bayer Recent Developments
 Table 89. Teva Corporation Information
 Table 90. Teva Description and Major Businesses
 Table 91. Teva Product Models, Descriptions and Specifications
 Table 92. Teva Capacity, Sales (Tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2020-2025)
 Table 93. Teva Sales Value Proportion by Product in 2024
 Table 94. Teva Sales Value Proportion by Application in 2024
 Table 95. Teva Sales Value Proportion by Geographic Area in 2024
 Table 96. Teva Quinine SWOT Analysis
 Table 97. Teva Recent Developments
 Table 98. Viatris Corporation Information
 Table 99. Viatris Description and Major Businesses
 Table 100. Viatris Product Models, Descriptions and Specifications
 Table 101. Viatris Capacity, Sales (Tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2020-2025)
 Table 102. Viatris Recent Developments
 Table 103. Ipca Laboratories Corporation Information
 Table 104. Ipca Laboratories Description and Major Businesses
 Table 105. Ipca Laboratories Product Models, Descriptions and Specifications
 Table 106. Ipca Laboratories Capacity, Sales (Tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2020-2025)
 Table 107. Ipca Laboratories Recent Developments
 Table 108. Huateng Pharma Corporation Information
 Table 109. Huateng Pharma Description and Major Businesses
 Table 110. Huateng Pharma Product Models, Descriptions and Specifications
 Table 111. Huateng Pharma Capacity, Sales (Tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2020-2025)
 Table 112. Huateng Pharma Recent Developments
 Table 113. Key Raw Materials Distribution
 Table 114. Raw Materials Key Suppliers
 Table 115. Critical Raw Material Supplier Concentration (2024) & Risk Index
 Table 116. Milestones in Production Technology Evolution
 Table 117. Distributors List
 Table 118. Market Trends and Market Evolution
 Table 119. Market Drivers and Opportunities
 Table 120. Market Challenges, Risks, and Restraints
 Table 121. Research Programs/Design for This Report
 Table 122. Key Data Information from Secondary Sources
 Table 123. Key Data Information from Primary Sources


List of Figures
 Figure 1. Quinine Product Picture
 Figure 2. Global Quinine Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
 Figure 3. Food Grade Product Picture
 Figure 4. Pharma Grade Product Picture
 Figure 5. Global Quinine Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
 Figure 6. Beverages
 Figure 7. Pharmaceuticals
 Figure 8. Others
 Figure 9. Quinine Report Years Considered
 Figure 10. Global Quinine Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 11. Global Quinine Revenue (2020-2031) & (US$ Million)
 Figure 12. Global Quinine Revenue (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Figure 13. Global Quinine Revenue Market Share by Region (2020-2031)
 Figure 14. Global Quinine Sales (2020-2031) & (Tons)
 Figure 15. Global Quinine Sales (CAGR) by Region (2020-2031) (Tons)
 Figure 16. Global Quinine Sales Market Share by Region (2020-2031)
 Figure 17. Global Quinine Capacity, Production and Utilization (2020-2031) & (Tons)
 Figure 18. Global Quinine Production Trend by Region (2020-2031) (Tons)
 Figure 19. Global Quinine Production Market Share by Region (2020-2031)
 Figure 20. Production Capacity Enablers & Constraints
 Figure 21. Quinine Production Growth Rate in North America (2020-2031) & (Tons)
 Figure 22. Quinine Production Growth Rate in Europe (2020-2031) & (Tons)
 Figure 23. Quinine Production Growth Rate in China (2020-2031) & (Tons)
 Figure 24. Quinine Production Growth Rate in Japan (2020-2031) & (Tons)
 Figure 25. Top 5 and Top 10 Manufacturers Quinine Sales Volume Market Share in 2024
 Figure 26. Global Quinine Revenue Market Share Ranking (2024)
 Figure 27. Tier Distribution by Revenue Contribution (2020 VS 2024)
 Figure 28. Food Grade Revenue Market Share by Manufacturer in 2024
 Figure 29. Pharma Grade Revenue Market Share by Manufacturer in 2024
 Figure 30. Type Eight Revenue Market Share by Manufacturer in 2024
 Figure 31. Type Nine Revenue Market Share by Manufacturer in 2024
 Figure 32. Global Quinine Sales Market Share by Type (2020-2031)
 Figure 33. Global Quinine Revenue Market Share by Type (2020-2031)
 Figure 34. Global Quinine Sales Market Share by Application (2020-2031)
 Figure 35. Global Quinine Revenue Market Share by Application (2020-2031)
 Figure 36. North America Quinine Sales YoY (2020-2031) & (Tons)
 Figure 37. North America Quinine Revenue YoY (2020-2031) & (US$ Million)
 Figure 38. North America Top 5 Manufacturers Quinine Sales Revenue (US$ Million) in 2024
 Figure 39. North America Quinine Sales Volume (Tons) by Type (2020- 2031)
 Figure 40. North America Quinine Sales Revenue (US$ Million) by Type (2020 - 2031)
 Figure 41. North America Quinine Sales Volume (Tons) by Application (2020-2031)
 Figure 42. North America Quinine Sales Revenue (US$ Million) by Application (2020-2031)
 Figure 43. US Quinine Revenue (2020-2031) & (US$ Million)
 Figure 44. Canada Quinine Revenue (2020-2031) & (US$ Million)
 Figure 45. Mexico Quinine Revenue (2020-2031) & (US$ Million)
 Figure 46. Europe Quinine Sales YoY (2020-2031) & (Tons)
 Figure 47. Europe Quinine Revenue YoY (2020-2031) & (US$ Million)
 Figure 48. Europe Top 5 Manufacturers Quinine Sales Revenue (US$ Million) in 2024
 Figure 49. Europe Quinine Sales Volume (Tons) by Type (2020-2031)
 Figure 50. Europe Quinine Sales Revenue (US$ Million) by Type (2020-2031)
 Figure 51. Europe Quinine Sales Volume (Tons) by Application (2020-2031)
 Figure 52. Europe Quinine Sales Revenue (US$ Million) by Application (2020-2031)
 Figure 53. Germany Quinine Revenue (2020-2031) & (US$ Million)
 Figure 54. France Quinine Revenue (2020-2031) & (US$ Million)
 Figure 55. U.K. Quinine Revenue (2020-2031) & (US$ Million)
 Figure 56. Italy Quinine Revenue (2020-2031) & (US$ Million)
 Figure 57. Russia Quinine Revenue (2020-2031) & (US$ Million)
 Figure 58. Asia-Pacific Quinine Sales YoY (2020-2031) & (Tons)
 Figure 59. Asia-Pacific Quinine Revenue YoY (2020-2031) & (US$ Million)
 Figure 60. Asia-Pacific Top 8 Manufacturers Quinine Sales Revenue (US$ Million) in 2024
 Figure 61. Asia-Pacific Quinine Sales Volume (Tons) by Type (2020- 2031)
 Figure 62. Asia-Pacific Quinine Sales Revenue (US$ Million) by Type (2020- 2031)
 Figure 63. Asia-Pacific Quinine Sales Volume (Tons) by Application (2020-2031)
 Figure 64. Asia-Pacific Quinine Sales Revenue (US$ Million) by Application (2020-2031)
 Figure 65. Indonesia Quinine Revenue (2020-2031) & (US$ Million)
 Figure 66. Japan Quinine Revenue (2020-2031) & (US$ Million)
 Figure 67. South Korea Quinine Revenue (2020-2031) & (US$ Million)
 Figure 68. China Taiwan Quinine Revenue (2020-2031) & (US$ Million)
 Figure 69. India Quinine Revenue (2020-2031) & (US$ Million)
 Figure 70. Central and South America Quinine Sales YoY (2020-2031) & (Tons)
 Figure 71. Central and South America Quinine Revenue YoY (2020-2031) & (US$ Million)
 Figure 72. Central and South America Top 5 Manufacturers Quinine Sales Revenue (US$ Million) in 2024
 Figure 73. Central and South America Quinine Sales Volume (Tons) by Type (2021-2031)
 Figure 74. Central and South America Quinine Sales Revenue (US$ Million) by Type (2020-2031)
 Figure 75. Central and South America Quinine Sales Volume (Tons) by Application (2020-2031)
 Figure 76. Central and South America Quinine Sales Revenue (US$ Million) by Application (2020-2031)
 Figure 77. Brazil Quinine Revenue (2020-2025) & (US$ Million)
 Figure 78. Argentina Quinine Revenue (2020-2025) & (US$ Million)
 Figure 79. Middle East, and Africa Quinine Sales YoY (2020-2031) & (Tons)
 Figure 80. Middle East and Africa Quinine Revenue YoY (2020-2031) & (US$ Million)
 Figure 81. Middle East and Africa Top 5 Manufacturers Quinine Sales Revenue (US$ Million) in 2024
 Figure 82. Middle East and Africa Quinine Sales Volume (Tons) by Type (2021-2031)
 Figure 83. South America Quinine Sales Revenue (US$ Million) by Type (2020-2031)
 Figure 84. Middle East and Africa Quinine Sales Volume (Tons) by Application (2020-2031)
 Figure 85. Middle East and Africa Quinine Sales Revenue (US$ Million) by Application (2020-2031)
 Figure 86. GCC Countries Quinine Revenue (2020-2025) & (US$ Million)
 Figure 87. Turkey Quinine Revenue (2020-2025) & (US$ Million)
 Figure 88. Egypt Quinine Revenue (2020-2025) & (US$ Million)
 Figure 89. South Africa Quinine Revenue (2020-2025) & (US$ Million)
 Figure 90. Quinine Industry Chain Mapping
 Figure 91. Regional Quinine Manufacturing Base Distribution (%)
 Figure 92. Quinine Production Process
 Figure 93. Regional Quinine Production Cost Structure
 Figure 94. Channels of Distribution (Direct Vs Distribution)
 Figure 95. Bottom-up and Top-down Approaches for This Report
 Figure 96. Data Triangulation
 Figure 97. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$4900

This license allows only one user to access the PDF.
Electronic (PDF)

$7350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$9800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Lukasiewicz Research Network

SIMILAR REPORTS

Global Quinine Supplement Market Research Report 2024
Global Quinine Dihydrochloride Injection Market Research Report 2025
Global Artemisinin Sales Market Report Competitive Analysis and Regional Opportunities 2025 2031
Global Quinine Hydrochloride API Market Research Report 2025
Artemisinine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Alkaloids Market Research Report 2025
Artemisinin API Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Food Grade Licorice Extract Market Research Report 2025
Global Cistanche Extract Market Insights Forecast to 2030
Global Cosmetics Grade Licorice Extract Market Research Report 2025
3R 3 Hydroxy Quinine Reagent Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Tonic Water Sales Market Report Competitive Analysis and Regional Opportunities 2025 2031
Global Fenugreek Extract Market Research Report 2024
Global Plant Insecticides Market Research Report 2024
Global Feed Grade Licorice Extract Market Research Report 2025
Global Quinoa Seed Extract Market Research Report 2024
Global Lanoxin API Market Insights Forecast to 2030
Global Liquorice Extract Market Insights Forecast to 2030
Artemisinic Acid Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Cypermethrin Insecticide Market Research Report 2025
Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions